Successful prophylaxis using activated prothrombin complex concentrates (aPCC) in a severe haemophilia A patient with inhibitor previously unresponsive to on-demand daily infusions of aPCC.

Furukawa, S; Nogami, K; Ogiwara, K; Yada, K; Shima, M

Furukawa, S; Nogami, K; Ogiwara, K; Yada, K; Shima, M.

Affiliation

Furukawa S; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Ogiwara K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Yada K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Shima M; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.

Haemophilia ; 23(5): e481-e484, 2017 09.

Article in En | MEDLINE | ID: mdl-28771891

Subject(s)

Blood Coagulation Factors/therapeutic use; Hemophilia A/drug therapy; Hemophilia A/immunology; Hemorrhage/complications; Hemorrhage/prevention & control; Blood Coagulation Factors/administration & dosage; Blood Coagulation Factors/pharmacology; Child; Hemophilia A/complications; Humans; Isoantibodies/immunology; Male; Treatment Failure

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation Factors / Hemophilia A / Hemorrhage Limits: Child / Humans / Male Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2017 Document type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google